2022-2023中国生命科学与医疗行业行业现状与展望分析报告.pdf
2022-2023 报告-2021 2022 15%17%20%48%1 1-10 10-50 50 28%55%17%5,000 5,000 1 1 69%4%24%3%/20%30%50%/7%18%10%65%2022 2022 1 17 2 17 60 2021 2021 1 50#1 2021 2021 32%47%18%3%34%32%29%5%28%38%31%3%31%35%31%4%50%25%25%0%47%21%32%0%27%64%0%9%35%28%30%7%28%56%17%0%38%31%26%5%1 33%17%33%17%16%53%26%5%2021 2022 2021 2020 2021 84%#2 2021 2021 2021 2021 2020 87%80%45%45%30%13%1 50#2 2021 93%79%31%48%28%21%（选项被选次数的 比例）100%75%75%50%0%0%64%82%55%55%36%9%89%67%56%50%33%6%100%83%17%50%33%17%2020 2021 2 4 1#3 2021 2021 83%67%55%52%43%69%51%57%35%20%/2022 2021/1 50#3 2021 86%69%45%69%31%77%60%60%46%13%/75%50%75%50%50%89%63%47%21%26%64%64%91%27%55%70%43%59%20%19%78%83%39%56%44%67%56%56%62%21%100%33%83%50%33%53%53%68%26%26%2021 2022 1 1 50#4 2021 2021 43%55%25%27%67%89%57%45%75%73%33%11%2021 IT 1 50#4 2021 69%69%100%67%75%90%35%31%0%33%25%30%8%6%0%0%0%10%69%10%/4/40 1 50#5/?2021 75%90%50%45%83%89%25%10%50%55%17%11%/80%1 50#5 2021 18%12%0%40%0%25%9%8%50%20%0%6%13%12%0%20%20%6%60%69%50%20%80%63%1/2022 1 50#6 2022 2022 38%28%18%13%2%34%50%64%33%28%28%25%9%17%39%24%33%28%10%27%17%6%3%25%2022 15%2022 10-15%2022 5-10%2022 5%2022 60%2022 10%2022 40 13 30%2022 15%25%2022 1 50#7 3-5 2022 47%35%17%2%38%75%64%33%44%41%18%33%50%21%25%9%33%6%9%47%57%10 17%2021 2022 62%62%58%52%37%20%10%#8 2022 大型企业1国有企业 私营企业 外商独资企业 中外合资企业 所有受访企业 4/1 50 3.633.323.203.071.733.213.262.342.981.78 2022 2021 1 2021 2022#9 2022 2021 3.693.383.103.281.553.353.332.772.901.73 3.503.502.753.252.003.053.161.893.631.373.823.363.002.552.273.113.352.302.741.763.393.673.613.061.283.623.032.492.921.82 1 50 2 2021 2022#9 2022 2021 2022 1 2021 2022 1 50#10 2022 78%67%44%44%39%39%17%11%1 2022 202020212022 2030 B2C 2022 2022 2022 2022 2022 2021 2022 2021 2022 2022 2022 2022 28%55%17%5,000 人以下5,000 1 万人1 万人以上10%31%59%董事长/CEO高层管理者其他管理者69%4%24%3%医药经销商/零售商医疗器械医疗服务7%14%79%国有企业私营企业中外合资企业外商独资企业 29/60 50 14 1 5 1=5 2=4 3=3 4=2 5=1 1*5+2*4+3*3+4*2+5*1/A 12 1 2 3 4 5 A(3*5)+(4*4)+(2*3)+(2*2)+(1*1)/12=3.58 A 3.58
